Plexion it Yoga

Acne. Redness. Flakiness.

We've been on it for decades.

Plexion® (sodium sulfacetamide 9.8%, sulfur 4.8%), the branded sodium sulfacetamide + sulfur therapy you know and trust to treat acne vulgaris, acne rosacea, and seborrheic dermatitis is back in a big way.1-5 And so is she.

Learn about Plexion®

The plexion family of products are always:

Trusted Ingredients.

Doctors have trusted the proven efficacy of sodium sulfacetamide + sulfur to take on acne, rosacea, and seborrheic dermatitis for years.1,6

Steroid Free.

Four steroid-free formulations to fight bacteria, reduce redness, and promote skin peeling in acute or chronic conditions.2-7

Low Odor.

Low in odor due to reduced sulfur content, so patients 12 years and up can use it daily with confidence.2-6

The Plexion Family

Plexion Cleanser

Plexion Cleanser

Plexion Lotion

Plexion Lotion

Plexion Cream

Plexion Cream

Plexion Cleansing Cloths

Plexion Cleansing Cloths

Plexion Cleanser

The Plexion

Cleanser

A treated cleanser to wash affected areas 1-2 times daily2,3
Low odor due to reduced sulfur content2,3,6

Plexion Lotion

The Plexion

Lotion

An elegant, leave-on therapy to apply up to 3 times daily4,5 
Low odor due to reduced sulfur content4-6

 

Plexion Cream

The Plexion

Cream

Reduces the redness associated with rosacea4-7 
Formulated to moisturizeand renew dry, flaky, and acne-prone skin4-7

Pexion Cleansing Cloths

The Plexion

Cleansing Cloths

Treated cleansing cloths allow patients to clean and treat while traveling
May use in conjunction with PLEXION® Cream or Lotion

REFERENCES:

1. Data on file.
2. PLEXION Cleanser [package insert]. 
3. PLEXION Cleansing Cloths [package insert]. 
4. PLEXION Cream [package insert]. 
5. PLEXION Lotion [package insert]. 
6. Wolf K, Silapunt S. The use of sodium sulfacetamide in dermatology. Cutis. 2015;96(2):128–130.
7. Sodium sulfacetamide 10%-sulfur 5% (SSS) for the topical treatment of seborrheic dermatitis, acne vulgaris, and rosacea. Poster presented at: 32nd Anniversary Fall Clinical Dermatology Conference; October 17-20, 2013; Las Vegas, NV.